Britannia Pharmaceuticals Revenue and Competitors

Reading, KS USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Britannia Pharmaceuticals's estimated annual revenue is currently $26.7M per year.(i)
  • Britannia Pharmaceuticals's estimated revenue per employee is $219,123

Employee Data

  • Britannia Pharmaceuticals has 122 Employees.(i)
  • Britannia Pharmaceuticals grew their employee count by 11% last year.

Britannia Pharmaceuticals's People

NameTitleEmail/Phone
1
Executive Assistant to Chief People OfficerReveal Email/Phone
2
Head PharmacovigilanceReveal Email/Phone
3
Head UK Sales & MarketingReveal Email/Phone
4
Head Market Access & PricingReveal Email/Phone
5
Head Quality and Regulatory AffairsReveal Email/Phone
6
Head Product DevelopmentReveal Email/Phone
7
PV OfficerReveal Email/Phone
8
Head NursingReveal Email/Phone
9
Pharmacovigilance OfficerReveal Email/Phone
10
Compliance OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$10.3M4610%N/AN/A
#2
$24.7M99-3%N/AN/A
#3
$5.6M259%N/AN/A
#4
$26.7M12211%N/AN/A
#5
$4.4M196%N/AN/A
#6
$74.6M3080%N/AN/A
#7
$22.7M941%N/AN/A
#8
N/A18-5%N/AN/A
#9
$12.3M858%$20MN/A
#10
$3.8M15-6%N/AN/A
Add Company

What Is Britannia Pharmaceuticals?

Britannia Pharmaceuticals, part of the STADA Arzneimittel AG group of companies, is a UK based pharmaceutical company specialising in the neurology market. \n\nBritannia focuses on innovative products for chronic and serious medical conditions, and in particular, the treatment of Parkinson’s disease. We are highly committed to improving the quality of life for People with Parkinson's disease. \n\nIf you are interested in viewing any of our current vacancies please go to: https://www.britannia-pharm.co.uk/careers.html

keywords:N/A

N/A

Total Funding

122

Number of Employees

$26.7M

Revenue (est)

11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Britannia Pharmaceuticals News

2022-04-17 - Global Apomorphine Delivery Device Market 2022 Growing ...

Manufacturers considered in the survey: Supernus Pharmaceuticals; Britannia Pharmaceuticals STADA; Ever Pharma; Evolan Pharma AB (PharmSwed).

2022-04-17 - Global Apomorphine Hydrochloride Injection Market 2022 Growth ...

Britannia Pharmaceuticals STADA; Ever Pharma; Evolan Pharma AB (PharmSwed). Market division by topographical areas: North America (United States...

2022-04-06 - Global Dry Powder Inhalation Market Developments and Products ...

... Bespak plc; Boehringer Ingelheim Pharma; Braunform GmbH; Breathable Foods, Inc. Britannia Pharmaceuticals Ltd. British American Tobacco...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.1M1221%N/A
#2
$20.2M123-18%N/A
#3
$33.2M1237%N/A
#4
$33.8M12517%N/A
#5
$32.9M12723%N/A